Protollin

N/A

Report date: 2026/01/27 10:54:49

Base Information

Drug NameProtollin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs
Mechanisms of ActionImmunostimulantsAmyloid beta-protein precursor inhibitorsMicrotubule-associated protein tau inhibitors
TargetsAmyloid beta-protein precursorMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Brigham and Women's Hospital
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalI-Mab Biopharma Us LtdI-Mab Biopharma Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A